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Adolescence Metabolic Syndrome or Adiposity and Early Adult
Metabolic Syndrome
Farhad Hosseinpanah, MD1, Golaleh Asghari, MS1, Maryam Barzin, MD, MPH1, Sahar Ghareh, MD2, and Fereidoun Azizi, MD3
Objective To investigate the predictive role of adolescent metabolic syndrome (MetS) in development of early
adult MetS, independent of adult body mass index (BMI).
Study design 1424 adolescents (639 boys), participants of the Tehran Lipid and Glucose Study, followed for 10.4
years, were analyzed and logistic regression models were developed. Using the areas under the receiver operating
characteristic curve, the discriminatory ability of adolescent MetS and overweight or obesity was evaluated. Net
reclassification improvement was calculated to determine the accuracy of classification by adolescent MetS in
place of overweight or obesity.
Results The mean  SD of age and BMI were 14.6  2.2 years and 20.3  4.2 kg/m2, respectively. The
prevalence of MetS was 13.3% and 14.6% at baseline and after follow-up, respectively. The risk of devel-
oping early adult MetS among subjects who were overweight or obese in adolescence but nonobese as
adults (OR: 1.65) was lower than the risk among subjects who were obese as adults but nonobese as
adolescents (OR: 8.45). After adjustment for adult BMI, adolescent MetS and overweight or obesity did
not show any association with the risk of adult MetS. Area under the receiver operating characteristic curve
was higher for obesity (0.619) than MetS (0.589) and the net reclassification improvement value for MetS was
1.5% (P = .398).
Conclusion Adolescent MetS or adiposity did not predict early adult MetS independent of adult BMI. The
addition of adolescent MetS to obesity does not improve the predictive power for early adult MetS. (J Pediatr
2013;163:1663-9).
M
etabolic syndrome (MetS) is a complex disorder defined by a cluster of interconnected factors including dyslipidemia,
elevated blood pressure, and dysregulated glucose homeostasis, with abdominal obesity and/or insulin resistance as
the core manifestations of the syndrome in both children and adults.1,2 Different proposed definitions of pediatric
MetS are modified from adult criteria with use of sex- and age-specific national curves; therefore, different prevalence of
MetS has been reported in different studies of children and adolescents.3
The clinical utility of pediatric MetS for identifying who develops MetS in adulthood is controversial.4-6 There is
substantial evidence on the predictive value of childhood MetS and increased risk of MetS, type 2 diabetes, and surrogates
of cardiovascular disease such as carotid intima-media thickness in adulthood.7 To date, the contribution of childhood MetS
to long-term MetS risk, independent of adult body mass index (BMI), has not been clearly established. Furthermore, some
studies report that some simpler screening tools such as BMI in pediatric settings seem to be equally useful compared with
pediatric MetS in identifying adolescents at risk of developing adult MetS.7 Moreover, the majority of studies addressing role
of childhood or adolescent BMI for prediction of adult MetS also failed to adjust for adult BMI.6,8 Interestingly, the findings
of 2 recent systematic reviews challenged the independent role of pediatric obesity for adult MetS and cardiovascular
disease.9,10
Therefore, it seems important to explore predictive factors in childhood or adolescents for prediction of early adult MetS.
Tracking of adiposity between childhood and adulthood would be important. In the current study, we aimed to investigate the
possible role of adolescent MetS on development of early adult MetS, independent of adult BMI among the Tehran Lipid and
Glucose Study (TLGS) during a mean follow-up of 10.4 years.From the 1Obesity Research Center, Research Institute
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BMI Body mass index
HDL-C High-density lipoprotein cholesterol
MetS Metabolic syndrome
NPV Negative predictive value
NRI Net reclassification improvement
PPV Positive predictive value
ROC Receiver operating characteristic
TG Triglyceride
TLGS Tehran Lipid and Glucose Study
WC Waist circumference
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This study was conducted within the framework of the TLGS,
a prospective study of the prevalence of noncommunicable
diseases and their risk factors among Tehran’s urban popula-
tion.11,12 The participants were followed up every 3 years; the
baseline survey was a cross-sectional study conducted from
1999-2001, and surveys 2 (2002-2005), 3 (2006-2008), and
4 (2009-2011) were prospective follow-up surveys. Multi-
stage cluster sampling was used to randomly select people
aged 3 years or older from district 13 of Tehran, the capital
of Iran. This population is served by 3 medical centers. The
age distribution of the population in district 13 is representa-
tive of the overall population of Tehran (Iran National
Census, 1996). Of the 15 005 subjects who participated in
baseline examination of the TLGS (1999-2001), 2688 subjects
were children and adolescents, aged 11-18 years (mean age
14.5  2.2 years, 48% male). For the current study, after
excluding those with missing anthropometric values and
biochemical data (n = 106), 2582 remained. Of 2582 children
and adolescents, 1424 (639 boys and 785 girls) aged 18-31
years, returned for follow-up with a mean of 10.2 years.
The protocols of this study were approved by the institu-
tional ethics committee of the Research Institute for
Endocrine Sciences, affiliated with the Shahid Beheshti Uni-
versity of Medical Sciences.
Anthropometric measurements including height, weight,
and waist circumference (WC) were measured by trained
examiners at baseline and at follow-up using standardized
protocols.11 Height was measured in a standing position,
without shoes, using a measuring tape while the shoulders
were in a normal position.Weight was measured using digital
scales (Seca 707; Seca Corporation, Hanover, Maryland;
range 0.1-150 kg) and was recorded to the nearest 100 g while
the subjects were minimally clothed and without shoes. BMI
(weight [kg]/square of height [m]) was calculated. WC was
measured at the umbilicus, using a measuring tape without
pressure to body surfaces and was recorded to the nearest
0.5 cm. Systolic and diastolic blood pressure was measured
using a standard mercury sphygmomanometer (calibrated
by the Iranian Institute of Standards and Industrial
Researches), in the right arm after 15-minute rest in a sitting
position. A qualified physician measured the blood pressure
of the seated subject twice; the mean of the 2 measurements
was used in the analysis. A blood sample was drawn into
vacutainer tubes from all subjects between 7:00 a.m. and
9:00 a.m. after 12-14 hours overnight fasting for measure-
ment of glucose and lipid concentrations. The samples were
centrifuged 30-45 minutes after collection. All analyses were
done at the TLGS research laboratory on the day of blood
collection. Fasting plasma glucose was measured by the enzy-
matic colorimetric method using glucose oxidase. Serum tri-
glyceride (TG) was assayed using an enzymatic colorimetric
method with glycerol phosphate oxidase, and serum total
cholesterol was assayed using an enzymatic colorimetric
method with cholesterol esterase and cholesterol oxidase.1664High-density lipoprotein cholesterol (HDL-C) was measured
after precipitation of the apolipoprotein B–containing lipo-
proteins with phosphotungstic acid. These analyses were
performed using commercial kits (Pars Azmoon Inc, Tehran,
Iran) and a Selectra 2 auto analyzer (Vital Scientific, Spanke-
ren, The Netherlands). Inter- and intra-assay coefficients of
variations at baseline were 2.2% for serum glucose, 2% and
0.5% for HDL-C, and 1.6% and 0.6% for TG, respectively.
Because no universally accepted definition of the MetS
exists for children, the definition proposed by Cook et al
was used.13 It definesMetS as 3 or more of the following: fast-
ing TGs $110 mg/dL; HDL-C <40 mg/dL; WC $90th
percentile for age and sex, according to national reference
curves14; systolic blood pressure and/or diastolic blood
pressure $90th percentile for sex, age, and height, from the
National Heart, Lung, and Blood Institute’s recommended
cut-off points;15 and fasting blood glucose $100 mg/dL,
according to the recent recommendations of American
Diabetes Association.16 The joint interim statement17
defines MetS as the presence of any 3 of 5 risk factors of
the following: (1) abdominal obesity as WC $91 cm for
women and $89 cm for men according to population- and
country-specific cut-off point for Iranians18; (2) fasting
plasma glucose $100 mg/dL or drug treatment; (3) fasting
TGs $150 mg/dL or drug treatment; (4) fasting HDL-C
<50mg/dL for women and <40mg/dL for men or drug treat-
ment; and (5) elevated blood pressure was defined as systolic
blood pressure $130 mm Hg, diastolic blood pressure $85
mm Hg, or antihypertensive drug treatment.
Obesity, overweight, and normal BMI were defined based
on the standardized percentile curves of BMI suggested for
Iranian children and adolescents as $95th, between $85th
and <95th, and <85th percentiles of BMI for age and sex,
respectively.19 To observe tracking of BMI from adolescence
into early adulthood, the participants were categorized into 4
groups on the basis of adiposity status in adolescence and
adulthood. Group I were defined as subjects with normal
BMI in adolescence who were nonobese as adults; group II,
those who were overweight or obese in adolescence but
nonobese as adults; group III, those with normal BMI in
adolescence who were obese as adults; and group IV, those
who were overweight or obese in adolescence and obese as
adults.Statistical Analyses
Baseline and follow-up characteristics of subjects were
expressed asmean and SD ormedian and IQR for continuous
variables and percentages for dichotomous variables. These
variables were compared among adiposity groups using the
one-way ANOVA for continuous variables and c2 test for
categorical variables. The variables without normal distribu-
tion were log transformed. Multiple logistic regression anal-
ysis was used to evaluate the predictive power of adolescent
MetS, overweight or obesity, and abdominal obesity for adult
MetS. ORs and 95% CIs were calculated for boys and girls.
Furthermore, the predictive power of adiposity groups forHosseinpanah et al
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characteristic (ROC) curve were estimated to compare the
prediction power of adolescent MetS, overweight or obesity,
and abdominal obesity for adult MetS. Sensitivity, specificity,
positive predictive value (PPV), and negative predictive value
(NPV) were calculated. The increased discriminative value of
adding adolescent MetS and abdominal obesity to adolescent
overweight or obesity model was further tested with net
reclassification improvement (NRI). NRI examined how
many individuals changed the status of adolescent over-
weight or obesity after addition of adolescent MetS or
abdominal obesity reporting the proportion of individuals
correctly reclassified across risk categories minus the propor-
tion of individuals incorrectly reclassified. The percentiles of
systolic and diastolic blood pressure were calculated accord-
ing to the fourth report on the diagnosis, evaluation, and
treatment of high blood pressure.20
The mean follow-up time was 10.4 years. Data analyses
were carried out by SPSS software package (v. 15; SPSS Inc,
Chicago, Illinois) and SAS software (v. 9.1; SAS Institute,
Cary, North Carolina) The statistical significance of differ-
ences between ROC curves was assessed using STATA soft-
ware package v. 10.0 (Stata Corporation, College Station,
Texas) according to the algorithm developed by Delong
et al21 and significance was set at P < .05.
Results
The study cohort consisted of 1424 subjects (639 boys and
785 girls) with a mean (SD) age of 14.6  2.2 years at base-
line. The mean length of follow-up was 10.4  1.0 years.
There were no significant differences in mean baseline
anthropometric measurements and biochemical assessments
between the subgroups of the cohort that provided follow-up
assessments and those lost at baseline (Table I; available at
www.jpeds.com).
Among 1121 subjects who had had normal weight as
children, 60 (5.3%) were obese as adults. Among 303 subjects
who had been obese as children, 141 (46.5%) were obese as
adults. The prevalence of abdominal obesity, MetS, and over-
weight or obesity among children were 15.3% (15.5% of boys
and 15.1% of girls), 13.3% (14.4% of boys and 12.4% of
girls), and 21.3% (23.3% of boys and 19.6% of girls), respec-
tively. After a 10-year follow-up, the prevalence of MetS was
14.6% (29.7% and 2.4% for adult males and females, respec-
tively). Adolescence and early adult characteristics of the
participants according to adiposity groups are displayed in
Table II. Compared with subjects in group I, those in
group IV had unfavorable cardiometabolic characteristics,
both during adolescence and adulthood (P < .05).
Adolescents in group II had higher adolescent weight, BMI,
WC, and TGs compared with those in group III (P < .05).
The prevalence of adolescent MetS was higher in group II
in comparison with group III (38.3% vs 11.7%, P < .05);
however, the prevalence of early adult MetS was higher
in group III in comparison with group II (45.0% vs 13.0%,
P < .05).Adolescence Metabolic Syndrome or Adiposity and Early Adult MThe risk of developing early adultMetS among subjects who
were overweight or obese in adolescence but nonobese as
adults (group II) was not significantly increased compared
with subjects who had normal BMI in adolescence but nonob-
ese as adults (group I). Subjects whowere obese as adults, irre-
spective of their adolescent adiposity status (groups III and IV)
had increased risks of developing early adultMetS (Table III).
The risk of early adult MetS tended to increase as the num-
ber of youthMetS components increased (P for trend <.001).
However, after adjustment for adult BMI, all associations
were not significant, except for boys who had 2 (2.52, 95%
CI: 1.37-4.64) or 3 (2.35, 95% CI: 1.12-4.93) MetS compo-
nents. The most frequent combination of unfavorable cardi-
ometabolic risk factors for boys with 2 or 3MetS components
were lowHDL-C and high TGs. AdolescentMetS, overweight
or obese, and abdominal obesity had independent associa-
tions with early adult MetS. However, after adjustment of
adult BMI, all associations were not significant, except for
adolescent abdominal obesity in boys (0.57, 95% CI: 0.33-
0.96), which was protective (Table IV).
All predictors had high NPV, indicating that normal BMI
orWC and lack of MetS in adolescence can accurately predict
lack of MetS in early adulthood. Also, all predictors had low
PPV, indicating that majority of adolescents with overweight
obesity, abdominal obesity, and MetS do not necessarily
develop MetS in early adulthood. Prediction of early adult
MetS by adolescent overweight or obesity using ROC analysis
was superior to the prediction provided by adolescent
abdominal obesity (P = .003). Additionally, compared with
adolescent MetS, borderline significance (P = .07) was
observed. As evidenced by net reclassification index values,
the accuracy of classification was not improved by adding
either adolescent MetS or abdominal obesity to adolescent
overweight or obesity for prediction of early adult MetS (all
P > .05, Table V).
Discussion
This study demonstrates the predictive power of adolescence
MetS or obesity for early adult MetS and the tracking of
adiposity between adolescence and adulthood for adult MetS
prediction. We found that adolescent MetS or excess weight
did not predict early adult MetS, independent of adult BMI
during a mean follow-up of 10.4 years. Also, the risk of devel-
oping MetS in early adulthood was lower among subjects who
were overweight or obese during adolescence but nonobese as
adults than among subjects who were consistently obese or
who became obese as adults. Furthermore, our analysis re-
vealed no marked change for the future MetS stratification
by adolescent MetS beyond adolescent obesity.
MetS is a subject of controversy in adolescence, which rai-
ses questions about the utility of the MetS as a diagnostic
category in a clinical setting. Barriers of using MetS are the
lack of consistent, accepted definition, the physiological
occurrence of insulin resistance in puberty, and the low sta-
bility of the MetS in children and adolescents.2,22 Moreover,
there is not enough evidence in favor of the independent roleetabolic Syndrome 1665
Table II. Participant characteristics during adolescence and adulthood according to adiposity groups
Group I: BMI <85th at
adolescence and <30
kg/m2 at adulthood
(n = 1061)
Group II: BMI ‡85th at
adolescence and <30
kg/m2 at adulthood
(n = 162)
Group III: BMI <85th at
adolescence and ‡30
kg/m2 at adulthood
(n = 60)
Group IV: BMI ‡ 85th
at adolescence and ‡30
kg/m2 at adulthood
(n = 141) P value*
Adolescence
Age (y) 14.4  2.2x 14.4  2.2x 15.5  2.1 14.9  2.2x .001
Male (%) 42.9 43.2 58.3 56.0 .004
Family history of diabetes
(%)
9.6 12.4 15.0 17.3 .029
BMI (kg/m2) 18.5  2.4z,x,{ 25.4  2.7x,{ 21.2  3.4{ 27.5  3.9 <.001
WC (cm) 65.5  7.0z,x,{ 80.3  8.4x,{ 72.8  6.3{ 85.9  10.4 <.001
Abdominal obesity (%) 3.3 50.3 8.5 68.1 < .001
Systolic blood pressure
(mm Hg)
102.9  10.8z,x,{ 110.4  10.5{ 108.4  9.9{ 114.4  12.6 <.001
Percentile 31.1  24.7z,{ 48.8  26.5x 35.2  25.7{ 55.0  28.7 <.001
Diastolic blood pressure
(mm Hg)
69.6  9.0z,{ 74.1  7.9{ 72.3  7.3{ 75.5  9.4 <.001
Percentile 65.6  26.4z,{ 78.0  21.7 69.7  22.8 79.1  23.8 <.001
Elevated blood pressure
(%)
13.9 30.0 21.7 38.1 <.001
HDL-C (mg/dL) 43.6  10.3{ 41.4  10.6 42.3  11.0 39.8  8.5 <.001
TGs (mg/dL)† 94.0 (71.0-126.0)z,{ 120 (88.0-162.2)x 94.0 (69.0-131.0){ 133.0 (93.5-188.5) <.001
Fasting plasma glucose
(mg/dL)
88.2  8.0z 90.6  7.9{ 87.6  8.8 87.9  7.7 .004
MetS (%) 5.2 38.3 11.7 46.1 <.001
Early adulthood
Age (y) 24.9  2.5x,{ 24.9  2.4x 26.2  2.3 25.5  2.6 <.001
BMI (kg/m2) 23.2  3.1z,x,{ 26.5  3.1x,{ 32.5  2.6{ 34.5  3.9 <.001
WC (cm) 81.6  9.2z,x,{ 89.0  9.2x,{ 103.2  8.4 106.1  12.7 <.001
Abdominal obesity (%) 21.7 45.1 93.3 91.5 <.001
Systolic blood pressure
(mm Hg)
105.0  11.7x,{ 107.6  11.8x,{ 116.1  12.2 118.6  13.3 <.001
Diastolic blood pressure
(mm Hg)
70.2  9.0x,{ 71.5  9.0x,{ 79.7  9.6 78.6  10.7 <.001
Elevated blood pressure
(%)
1.8 3.1 18.3 18.7 <.001
HDL-C (mg/dL) 49.7  11.6x,{ 49.6  11.7x,{ 41.7  8.6 43.2  9.6 <.001
TGs (mg/dL)† 84.0 (64.5-115.0)x,{ 82.0 (64.7-117.2)x,{ 127.0 (103.0-172.5) 123.0 (90.0-169.5) <.001
Fasting plasma glucose
(mg/dL)
88.9  15.2 89.1  7.7 90.4  6.3 91.9  15.7 .106
MetS (%) 9.0 13.0 45.0 46.8 <.001
Data are mean  SD or median (IQ 25-75) unless otherwise noted.
*P values are for the comparisons across groups, with the use of ANOVA for continuous and c2 test for categorical variables.
†Log transformed values were used for comparison.
zSignificantly different from group II, using post hoc Scheffe analysis test.
xSignificantly different from group III, using post hoc Scheffe analysis test.
{Significantly different from group IV, using post hoc Scheffe analysis test.
THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 163, No. 6of adolescent MetS for future MetS prediction. For example,
the Bogalusa Heart Study did not consider the adult BMI
in evaluating the association between adolescent and
adult MetS.7 Similarly, our unadjusted analysis indicated an
association between adolescent MetS and early adult MetS;
however, after adjusting the adult BMI, no association wasTable III. ORs and 95% CI of developing early adulthood M
(
Group I: BMI <85th at adolescence and <30 kg/m2 at adulthood (n = 1061)
Group II: BMI $85th at adolescence and <30 kg/m2 at adulthood (n = 162) 1.62
Group III: BMI <85th at adolescence and $30 kg/m2 at adulthood (n = 60) 8.45
Group IV: BMI $ 85th at adolescence and $30 kg/m2 at adulthood (n = 141) 9.87
P for trend
*Unadjusted.
†Adjusted for sex.
1666observed except for some combinations of cardiometabolic
risk factors.
Interestingly, combinations of 2 or 3 elements of MetS
remained significant after adjustment for adult BMI. Further
analysis revealed that combination of low HDL-C and high
TGs or the combination of low HDL-C, high TGs, andetS in adiposity groups
Boys Girls Total
OR*
95% CI)
P
value
OR*
(95% CI)
P
value
OR†
(95% CI)
P
value
1.00 1.00
(0.92-2.86) .095 1.32 (0.15-11.43) .800 1.59 (0.92-2.74) .094
(4.18-18.73) <.001 16.39 (3.68-72.96) <.001 9.66 (4.93-18.91) <.001
(5.77-16.90) <.001 23.11 (7.62-70.16) <.001 11.82 (7.27-19.23) <.001
<.001 <.001 <.001
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Table IV. OR (95% CI) of developing MetS in early adulthood based onmetabolic and obesity characteristics in 639 boys
and 785 girls
Boys (n = 639) Girls (n = 785) Total (n = 1424)
Unadjusted
Adjusted for
adult BMI Unadjusted
Adjusted for
adult BMI Unadjusted
Adjusted
for sex
Adjusted for sex
and adult BMI
No. of MetS
components
0 1.00 1.00 1.00 1.00 1.00 1.00 1.00
1 1.74 (1.05-2.89)
.03
1.35 (0.77-2.38)
.29
3.05 (0.63-14.83)
.17
4.02 (0.70-23.2)
.12
1.88 (1.19-2.98)
.007
1.85 (1.14-3.00)
.012
1.54 (0.91-2.62)
.11
2 3.85 (2.25-6.58)
<.001
2.52 (1.37-4.64)
.003
2.13 (0.39-11.77)
.38
1.58 (0.24-10.21)
.63
2.60 (1.62-4.17)
<.001
3.55 (2.14-5.89)
<.001
2.33 (1.32-4.11)
.003
3 7.26 (3.90-13.54)
<.001
2.35 (1.12-4.93)
.024
6.19 (1.11-34.52)
.037
2.93 (0.44-19.28)
.26
5.52 (3.29-9.26)
<.001
7.05 (3.95-12.56)
<.001
2.44 (1.25-4.76)
.009
$4 7.88 (3.18-19.56)
<.001
0.43 (0.13-1.41)
.16
11.74 (1.56-88.05)
.017
2.84 (0.28-28.46)
.38
7.13 (3.48-14.62)
<.001
8.58 (3.73-19.76)
<.001
0.67 (0.23-1.95)
.48
P for trend <.001 .069 <.001 .57 <.001 <.001 .047
Adolescence MetS 3.96 (2.53-6.21)
<.001
1.08 (0.61-1.93)
.78
3.49 (1.29-9.41)
.014
1.39 (0.45-4.26)
.56
3.32 (2.34-4.71)
<.001
3.88 (2.58-5.83)
<.001
1.16 (0.70-1.94)
.56
Adolescence
abdominal
obesity
3.17 (2.05-4.89)
<.001
0.47 (0.26-0.85)
.013
4.41 (1.74-11.21)
.002
1.00 (0.33-3.05)
.996
2.74 (1.95-3.86)
<.001
3.36 (2.26-4.98)
<.001
0.57 (0.33-0.96)
.035
Adolescence
overweight or
obese
3.40 (2.32-4-98)
<.001
0.60 (0.35-1.01)
.056
6.01 (2.38-15.21)
<.001
0.98 (0.30-3.20)
.98
3.30 (2.42-4.50)
<.001
3.70 (2.60-5.26)
<.001
0.67 (0.41-1.07)
.096
Abdominal obesity was defined as WC $90th national percentile.
Overweight or obesity was defined as BMI $85th national percentile.
December 2013 ORIGINAL ARTICLESabdominal obesity are the more prevalent patterns. These find-
ings are in agreement with a previous cross-sectional report
from the TLGS, suggesting the hypertriglyceridemic waist
phenotype as a simple marker of identifying adolescents at
risk ofMetS and othermetabolic abnormalities.23More impor-
tantly, these findings indicate that some combinations of
individual components included in thedefinitionsof the adoles-
cent MetS would be more predictive than the whole syndrome
and could provide evidence in favor of unequal weight ofTable V. Sensitivity, specificity, PPV, NPV, AUC, and NRI v
abdominal obesity in predicting early adulthood MetS
Sensitivity (%) Specificity (%) PPV (%)
Total
Overweight
or obesity
42 82 29
MetS 28 89 31
Abdominal
obesity
29 87 28
Boys
Overweight
or obesity
40 84 51
MetS 28 91 57
Abdominal
obesity
52 75 28
Girls
Overweight
or obesity
58 81 7
MetS 32 88 6
Abdominal
obesity
42 86 7
AUC, area under the curve.
*P =.07 in comparison to MetS using c2 test.
†P = .003 in comparison to abdominal obesity using c2 test.
zP = .02 in comparison to abdominal obesity using c2 test.
Adolescence Metabolic Syndrome or Adiposity and Early Adult Mdifferent components. Unexpectedly, abdominal obesity
remained as a protective variable in the final model (0.57,
95% CI: 0.33-0.96). One explanation behind this observation
is the high occurrence of normal adult BMI (53%) in those
adolescents with abdominal obesity, which probably reversed
the expected association of abdominal obesity.
Giving the importance of tracking BMI from adolescence
to adulthood and similar to the findings of Juonala et al,24
we found that subjects, who had normal BMI in adolescencealues for adolescence MetS, overweight or obesity, and
NPV (%) AUC 95% CI NRI (%) P value
89 0.619*,† 0.576-0.663 - -
88 0.589 0.544-0.633 1.51% .398
88 0.580 0.536-0.624 <0.1% .399
77 0.618z 0.569-0.668 - -
75 0.596 0.545-.646 3.05% .397
89 0.584 0.534-0.634 <0.1% .399
99 0.696 0.564-0.829 - -
98 0.599 0.457-0.742 <0.1% .399
98 0.640 0.498-0.781 <0.1% .399
etabolic Syndrome 1667
THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 163, No. 6butwho became obese as adults, had risk of adultMetS similar
to those who were consistently obese; however, those who
were overweight or obese as children but who became nonob-
ese as adults had aMetS risk that was similar to that of persons
who were never obese. From the practical point of view, in
spite of lack of knowledge of adult BMI and based on the cur-
rent analysis, whenwe are facedwith overweight or obese chil-
dren, we can advise them to get to an appropriate BMI in the
future to prevent MetS in adult years. Moreover, we found
low PPV and high NPV of adolescent obesity and MetS for
early adult MetS, indicating that adolescent obesity or MetS
could be a useful screening tool for identifying adolescents
who are not at risk for development of adult MetS. In spite
of nonsignificant values, using ROC analysis, it seems that
adolescent obesity had higher area under curve compared
with MetS, challenging the clinical utility of accepted pediat-
rics MetS definition. However, obesity in adolescence had a
higher area under curve compared with abdominal obesity.
The area under the curve values were lower than 0.7, meaning
that the prediction can be interpreted as fair.
Using sophisticated analysis, NRI showed nonsignificant
values for adolescent MetS, suggesting that adding adoles-
cent MetS to a model with adolescent obesity does not
increase the predictive ability of obesity for early adult
MetS. Our findings in terms of NRI are in line with the
Bogalusa Heart Study,7 which did not show any superiority
for adolescent MetS in comparison with those of adolescent
obesity by high BMI.
The findings in this report are subject to some limitations.
First, the present studyhad high rate of loss to follow-up.How-
ever, there were no significant differences between subjects lost
to follow-up and those provided follow-up assessments.
Furthermore, some possible confounders such as physical ac-
tivity, dietary habits, and socioeconomic status were not taken
into account. Given the low incidence of MetS in girls, this
study was not adequately powered for sex-stratified subgroup
analysis. Finally, the stage of puberty was not considered in
our analysis. There are strengths of the current survey. There
was a relatively large sample size. We also used national cut
points for defining MetS in adolescence and adulthood.
Considering the complexity surrounding the various defi-
nitions of adolescent MetS, our results potentially propose
independent roles for some combinations of risk factors
especially the hypertriglyceridemic waist. However, the clin-
ical utility of these combinations should be further analyzed
in long-term cohort studies. n
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tors. N Engl J Med 2011;365:1876-85.Autoimmune Disorders of Endocrine Glands
Solomon IL, Blizzard RM. J Pediatr 1963;63:1021-33
In their insightful article, Solomon and Blizzard reviewed data that substantiated Witebsky’s postulates pointing toautoimmunity in 3 endocrine diseases: Hashimoto’s thyroiditis, Addison’s disease, and male infertility. They
correctly hypothesized that additional ‘idiopathic’ endocrine disorders would have a similar autoimmune etiology
including diabetes, hypoparathyroidism, panhypopituitarism, and ovarian failure.
These investigators implicated a disturbance in immune tolerance, but precise mechanisms were lacking. The role
and identity of environmental triggers in a genetically susceptible individual, as well as the indolent nature of
autoimmunity prior to overt disease were not discussed.1
We have discovered many molecular and cellular entities required to establish and maintain central and peripheral
self-tolerance. T-cell subsets are the key mediators in autoimmune thyroiditis and adrenal failure and type 1 diabetes.
B-cell subsets contribute to autoimmunity through antigen presentation, cytokine synthesis, and auto-antibody
production. Many target antigens have been identified; antibodies to these help us predict, diagnose, and follow
disease activity.2
In this genetic era, monogenic causes of autoimmunity have produced insight into pathways to tolerance (for
exampleAIRE: genetic defects cause autoimmune polyendocrinopathy candidiasis and ectodermal dystrophy/autoim-
mune polyglandular syndrome-1). Genome-wide association studies and observations of phenotypic variability
among individuals with the same mutations have lead to appreciation of the role of multiple protective and suscep-
tibility loci, both within and beyond the major histocompatibility complex locus. Discovery of epigenetic control of
many immune cell functions raises additional questions about the role of DNA methylation, histone modifications,
and noncoding microRNA in the development of tolerance to self.3
Drugs and biologics to treat/delay onset of more serious autoimmune endocrinopathies have emerged including
nonselective antiproliferative agents, agents that selectively block cytokine-mediated lymphocyte stimulation, T- and
B-cell depletion with monoclonal antibodies and peptide antagonists, and fusion proteins that target kinases.3,4 In
short, we have come a long way, but it behoves us to remember those who set the stage.
Cheri L. Deal, MD, PhD
Chief, Endocrine Service
Centre Hospitalier Universitaire Sainte-Justine
University of Montreal
Montreal, Quebec, Canada
Alan D. Rogol, MD, PhD
Division of Endocrinology
University of Virginia
Charlottesville, Virginia
http://dx.doi.org/10.1016/j.jpeds.2013.06.001
References
1. Selmi C, Leung PSC, Sherr DH, Diaz M, Nyland JF, Monestrir M, et al. Mechanisms of environmental influence on human autoimmunity:
a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 2012;39:272-84.
2. Anderson MS. Update in endocrine autoimmunity. J Clin Endocrinol Metab 2008;93:3663-70.
3. Greer JM, McCombe PA. The role of epigenetic mechanisms and processes in autoimmune disorders. Biologics Targets Ther 2012;6:307-27.
4. Michels AW, Eisenbarth GS. Immunologic endocrine disorders. J Allergy Clin Immunol 2010;125(Suppl 2):S226-37.etabolic Syndrome 1669
Table I. Comparison of baseline characteristics between
subjects followed-up and missed to follow-up
Follow-up
(n = 1424)
Missed
to follow-up
(n = 1264)
P
value
Age (y) 14.5  2.2 14.5  2.3 .163
Weight (kg) 51.4  14.4 51.3  15.0 .159
Height (cm) 158.0  11.3 158.0  11.7 .108
BMI (kg/m2) 20.3  4.2 20.2  4.3 .223
WC (cm) 69.5  10.5 69.7  10.8 .211
Fasting blood glucose (mg/dL) 88.4  8.0 89.0  12.5 .578
HDL-C (mg/dL) 42.9  10.3 42.9  10.2 .849
TGs (mg/dL) 112.7  57.8 109.2  65.3 .603
Systolic blood pressure (mm Hg) 105.1  11.6 105.5  12.2 .030
Diastolic blood pressure (mm Hg) 70.8  9.1 71.3  9.3 .808
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